Acrongenomics on Track to Acquire Molecular Vision
Acrongenomics, Inc. have agreed with Molecular Vision and The Imperial Venture Fund a time line for the full acquisition of Molecular Vision. Following the initial acquisition of 10.9% of the shares of Molecular Vision announced earlier this month, it has now been agreed by all parties that the full acquisition of Molecular Vision will be completed before the end of Q1 2008.
In May 2006, Acrongenomics first identified the combination of microfluidics and light responsive polymers being developed by Molecular Vision as having the potential of completely revolutionising the Point of Care (PoC) diagnostics market. In a simple to use compact hand held device the analytical capabilities of a number of standard pieces of laboratory equipment can be duplicated. This means that a very wide range of diagnostic tests based on the same procedures that are used in the laboratory, will now be available to be undertaken in a physicians office, or even in the field if you were, for example, trying to identify an outbreak of infectious disease in farm animals. This wide utility was identified by Acrongenomics and resulted in them investing US $ 4.6 million in Molecular Vision in order to build a prototype of the hand held device and undertake trials comparing the results obtained with the device with those obtained from standard pieces of equipment routinely used in Pathology Laboratories. The results of comparative trial measuring creatinine in urine will be presented comparing the Molecular Vision device with the Siemens DCA 2000.
According to the company, these results have shown good correlation. A further comparative trial measuring vitamin C is underway and various blood based tests are being planned. Once these comparative trials are completed, the company will then commercialise the first diagnostic panel to monitor kidney function, followed by vitamin C monitoring.
Other news from the department business & finance
These products might interest you
tritec® Chromatographic refrigerators by tritec für Labortechnik und Umweltsimulation
Energy-efficient chromatography refrigerators for precise temperature control
Safe storage of your HPLC systems at -5 °C to 20 °C with modern touchscreen display
SmartCheck by Mettler-Toledo
Check Pipette Dosing Accuracy - Lightning Fast in Under a Minute
Detect dosing errors before it gets expensive
BIOS ANALYTIQUE - Soluciones de Renting y Leasing para laboratorios by Bios Analytique
Specialists in the rental and leasing of scientific equipment for laboratories throughout Europe
Whether you have an unexpected requirement or limited budget, we have the perfect solution for you
Starlab Minizentrifuge by STARLAB
The Starlab Minicentrifuge - ahead of the curve
This compact unit delivers quiet, intuitive and smooth operation along with a modern design
KNAUER IJM NanoScaler by KNAUER
Efficient formulation of lipid nanoparticles for RNA-based therapies
Optimise drug encapsulation from 1 ml to hundreds of millilitres with minimal drug input
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
